Breaking News, Collaborations & Alliances

Thermo Fisher Partners with Software Firm MSAID

To develop and commercialize tools to open new insights in proteomics research

By: Contract Pharma

Contract Pharma Staff

Thermo Fisher Scientific and MSAID GmbH, a software company transforming proteomics with deep learning, have formed an exclusive license agreement to develop and commercialize deep learning tools for proteomics, making MSAID’s Prosit-derived framework widely accessible to proteomics laboratories. The availability of deep learning tools will enable improved confidence in proteomics research results, primarily in the areas of protein profiling using label-free or tandem mass tag (TMT)-based quanti...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters